Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.
The Company issued approximately 1.6 million shares of common stock at a purchase price of $5.00 per share. The private placement was made directly by the Company without an underwriter or placement agent.
The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Avital Perlman.
- Sichenzia Ross Ference LLP Represents Spartan Capital Securities LLC and Pacific Century Securities LLC in $14.1 Million Initial Public Offering of Common Shares of Lytus Technologies Holdings PTV. Ltd. - June 22, 2022
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $10 Million Private Placement of SciSparc Ltd. - June 2, 2022
- Sichenzia Ross Ference LLP Represents The Singing Machine, Inc., in $4 Million Underwritten Public Offering and Uplisting to Nasdaq - May 26, 2022